Landmarks in non-muscle-invasive bladder cancer
Authors:
- 1 August 2014
- journal article
- Published by Springer Nature in Nature Reviews Urology
- Vol. 11 (8) , 476-480
Abstract
Bladder cancer is divided into two entities: non-muscle-invasive (NMIBC) and muscle invasive bladder cancer. NMIBC represents 75% of primary diagnoses and is characterized by frequent recurrence but a low risk of mortality. Throughout urological history, significant progress in detection, diagnosis, and treatment of NMIBC has been made. However, bladder cancer remains a heterogeneous disease with varying pathology, molecular background, diagnostic options, and subsequent therapies for the individual patient. Although significant progress has been made over the years, the improvement of bladder cancer outcomes remains the goal of future research.Keywords
This publication has 64 references indexed in Scilit:
- EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013European Urology, 2013
- The 1973 WHO Classification Is More Suitable than the 2004 WHO Classification for Predicting Prognosis in Non-Muscle-Invasive Bladder CancerPLOS ONE, 2012
- Extravasation of Intravesical Chemotherapy for Non-Muscle-Invasive Bladder CancerUrologia Internationalis, 2012
- Where next for the endoscope?Nature Reviews Urology, 2009
- An Individual Patient Data Meta-Analysis of the Long-Term Outcome of Randomised Studies Comparing Intravesical Mitomycin C versus Bacillus Calmette-Guérin for Non–Muscle-Invasive Bladder CancerEuropean Urology, 2009
- Genomics: a preview of genomic medicineBJU International, 2008
- The Schedule and Duration of Intravesical Chemotherapy in Patients with Non–Muscle-Invasive Bladder Cancer: A Systematic Review of the Published Results of Randomized Clinical TrialsEuropean Urology, 2008
- Molecular subtypes of bladder cancer: Jekyll and Hyde or chalk and cheese?Carcinogenesis, 2005
- Molecular Grading of Urothelial Cell Carcinoma With Fibroblast Growth Factor Receptor 3 and MIB-1 is Superior to Pathologic Grade for the Prediction of Clinical OutcomeJournal of Clinical Oncology, 2003
- Optical Biopsy in Human Urologic Tissue Using Optical Coherence TomographyJournal of Urology, 1997